eZine

Acne: FDA Approved Aczone For Acne Treatment

The U.S. Food and Drug Administration (FDA) approved to market Aczone (dapsone) Gel, 5 per cent for acne vulgaris topical treatment. But patients who have the enzyme deficiency, G6PD (Glucose 6-phosphate dehydrogenase), will need to be monitored with regular blood counts to detect if they are predisposed to one type of anemia (hemolytic anemia). Aczone, […]

This article is only available to members. Please Login or register.
Exit mobile version